Healthcare provider profile · identity verified

Laura M. Ferries, MD

Internal Medicine · SHERIDAN, WY · NPI 1700827557

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Furosemide	Furosemide	345	30
Eliquis	Apixaban	336	23
Pantoprazole Sodium	Pantoprazole Sodium	297	37
Levothyroxine Sodium	Levothyroxine Sodium	253	36
Metoprolol Succinate	Metoprolol Succinate	253	31
Potassium Chloride	Potassium Chloride	219	27
Gabapentin	Gabapentin	170	23
Trazodone Hcl	Trazodone Hcl	166	25
Escitalopram Oxalate	Escitalopram Oxalate	145	21
Losartan Potassium	Losartan Potassium	141	21
Amlodipine Besylate	Amlodipine Besylate	138	20
Atorvastatin Calcium	Atorvastatin Calcium	133	21
Quetiapine Fumarate	Quetiapine Fumarate	132	17
Omeprazole	Omeprazole	107	19
Buspirone Hcl	Buspirone Hcl	98	13
Lorazepam	Lorazepam	91	24
Carvedilol	Carvedilol	90	suppressed
Bumetanide	Bumetanide	76	suppressed
Lisinopril	Lisinopril	69	suppressed
Cephalexin	Cephalexin	68	16
Aripiprazole	Aripiprazole	66	suppressed
Levofloxacin	Levofloxacin	64	20
Xarelto	Rivaroxaban	64	suppressed
Tramadol Hcl	Tramadol Hcl	63	18
Tamsulosin Hcl	Tamsulosin Hcl	62	suppressed
Baclofen	Baclofen	60	suppressed
Duloxetine Hcl	Duloxetine Hcl	59	suppressed
Metformin Hcl	Metformin Hcl	59	suppressed
Fluticasone Propionate	Fluticasone Propionate	58	12
Spironolactone	Spironolactone	58	suppressed
Allopurinol	Allopurinol	54	11
Carbidopa-Levodopa	Carbidopa/Levodopa	53	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	52	suppressed
Finasteride	Finasteride	51	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	51	36
Triamcinolone Acetonide	Triamcinolone Acetonide	51	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	51	suppressed
Tresiba Flextouch U-100	Insulin Degludec	49	suppressed
Breo Ellipta	Fluticasone/Vilanterol	48	suppressed
Januvia	Sitagliptin Phosphate	46	suppressed
Methenamine Hippurate	Methenamine Hippurate	43	suppressed
Hydralazine Hcl	Hydralazine Hcl	41	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	41	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	40	11
Cefdinir	Cefdinir	39	11
Fiasp Flextouch	Insulin Aspart (Niacinamide)	39	suppressed
Rivastigmine	Rivastigmine Tartrate	38	suppressed
Sertraline Hcl	Sertraline Hcl	37	suppressed
Ondansetron Hcl	Ondansetron Hcl	36	11
Paroxetine Hcl	Paroxetine Hcl	36	suppressed
Pravastatin Sodium	Pravastatin Sodium	36	suppressed
Divalproex Sodium	Divalproex Sodium	35	suppressed
Nystatin	Nystatin	34	17
Hydroxyzine Hcl	Hydroxyzine Hcl	33	suppressed
Memantine Hcl	Memantine Hcl	33	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	33	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	32	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	31	suppressed
Jardiance	Empagliflozin	31	suppressed
Famotidine	Famotidine	30	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	30	suppressed
Citalopram Hbr	Citalopram Hydrobromide	29	suppressed
Azithromycin	Azithromycin	28	11
Montelukast Sodium	Montelukast Sodium	28	suppressed
Amoxicillin	Amoxicillin	27	suppressed
Clopidogrel	Clopidogrel Bisulfate	27	suppressed
Novofine Autocover	Pen Needle, Diabetic, Safety	27	suppressed
Spiriva Respimat	Tiotropium Bromide	27	suppressed
Trimethoprim	Trimethoprim	27	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	26	21
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	suppressed
Memantine Hcl Er	Memantine Hcl	25	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	24	suppressed
Prednisone	Prednisone	24	suppressed
Bupropion Xl	Bupropion Hcl	23	suppressed
Fentanyl	Fentanyl	23	suppressed
Mirtazapine	Mirtazapine	23	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	22	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Levetiracetam	Levetiracetam	21	suppressed
Torsemide	Torsemide	21	suppressed
Clonazepam	Clonazepam	20	suppressed
Albuterol Sulfate	Albuterol Sulfate	19	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	19	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Alprazolam	Alprazolam	18	suppressed
Meloxicam	Meloxicam	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Digoxin	Digoxin	17	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	17	suppressed
Rivastigmine	Rivastigmine	17	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	suppressed
Celecoxib	Celecoxib	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Topiramate	Topiramate	16	suppressed
Morphine Sulfate	Morphine Sulfate	15	15
Olanzapine	Olanzapine	15	suppressed
Oxcarbazepine	Oxcarbazepine	15	suppressed
Oxycodone Hcl	Oxycodone Hcl	15	suppressed
Telmisartan	Telmisartan	15	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Fluconazole	Fluconazole	14	suppressed
Incruse Ellipta	Umeclidinium Bromide	14	suppressed
Pregabalin	Pregabalin	14	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	13	suppressed
Diltiazem Hcl	Diltiazem Hcl	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Indapamide	Indapamide	13	suppressed
Insulin Aspart Flexpen	Insulin Aspart	13	suppressed
Insulin Degludec Pen (U-100)	Insulin Degludec	13	suppressed
Nebivolol Hcl	Nebivolol Hcl	13	suppressed
Primidone	Primidone	13	suppressed
Trospium Chloride	Trospium Chloride	13	suppressed
Budesonide Ec	Budesonide	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Tetrabenazine	Tetrabenazine	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	12	suppressed
Atropine Sulfate	Atropine Sulfate	11	suppressed
Ceftriaxone	Ceftriaxone Sodium	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error